Dentists in Boxborough, MA Accepting Medicare

1 Dentists found. Showing 1 - 1

Dr. Anna Y Kalmanovich, D.M.D. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 629 Massachusetts Ave, Boxborough, MA 01719 Phone: 978-263-8950    Fax: 978-263-1404

News Archive

KKR to acquire minority stake in Gland Pharma for about $200 million

Gland Pharma Limited, a leading Indian pure-play generic injectable pharmaceutical products company, today announced an agreement under which KKR, a leading global investment firm, will acquire a minority stake in the Company for approximately US$200 million, including KKR's acquisition of the entire stake held by Evolvence India Life Sciences Fund, an existing private equity investor in Gland Pharma.

Marijuana use could pose serious cognitive function risk later in life

Marijuana is the most frequently used illicit drug in the United States, according to a recent survey from the National Survey on Drug Use and Health, and new data suggest that marijuana use now could pose a serious cognitive function risk later in life.

Findings shed light on the role of environmental event in development of neural circuits in newborns

Neurons that process sensory information such as touch and vision are arranged in precise, well-characterized maps that are crucial for translating perception into understanding. A study published by Cell Press on October 14 in the journal Developmental Cell reveals that the actual act of birth in mice causes a reduction in a brain chemical called serotonin in the newborn mice, triggering sensory maps to form.

Discovery Labs receives FDA guidance to gain Surfaxin approval for RDS in premature infants

Discovery Laboratories, Inc. announces today that it has received written guidance from the U.S. Food and Drug Administration (FDA) that is consistent with its ongoing, comprehensive preclinical program to resolve the sole remaining chemistry, manufacturing & control (CMC) issue necessary to potentially gain FDA marketing approval for Surfaxin® (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants.

Read more Medical News

› Verified 3 days ago